Joana T. Vieira

ORCID: 0000-0003-3110-1528
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Erythropoietin and Anemia Treatment
  • Iron Metabolism and Disorders
  • Hemoglobinopathies and Related Disorders
  • Heart Failure Treatment and Management
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Takotsubo Cardiomyopathy and Associated Phenomena
  • Pharmaceutical Practices and Patient Outcomes
  • Systemic Lupus Erythematosus Research
  • Medical Coding and Health Information
  • Electrolyte and hormonal disorders
  • Cardiovascular Issues in Pregnancy
  • Healthcare Policy and Management
  • Platelet Disorders and Treatments
  • Coronary Artery Anomalies
  • Emergency and Acute Care Studies

Hospital de São João
2023-2024

Acute heart failure (AHF) is one of the main causes unplanned hospitalization in patients >65 years age and associated with adverse outcomes this population. Observational studies suggest that intravenous diuretic therapy given first hour presentation for AHF was favorable outcomes.To study short-term prognostic associations timing admitted to emergency department (ED) acute AHF.Patients treated ED diuretics were selected from Estratificação de Doentes com InsuFIciência Cardíaca Aguda...

10.1097/mej.0000000000001006 article EN European Journal of Emergency Medicine 2023-02-01

Spontaneous coronary artery dissection (SCAD) is an uncommon cause of acute myocardial infarction, caused by a non-traumatic and non-iatrogenic separation the arterial wall, especially amongst young women with no conventional cardiovascular risk factors. We describe case 46-year-old woman past medical history Cushing's disease, treated surgically, who presented SCAD. disease not considered traditional factor for As there are reported cases dissections associated this entity common causes...

10.7759/cureus.36370 article EN Cureus 2023-03-19

Abstract Background Intravenous iron improves symptoms in heart failure (HF) with deficiency (ID) but failed to consistently show a benefit cardiovascular outcomes. The ID definition used may influence the response intravenous iron. aim of this meta-analysis is assess on effect HF. Methods/Results We performed random-effects randomized controlled trials (RCT) (vs. placebo or standard care) patients HF and that provided data transferrin saturation (TSAT) ferritin subgroups composite outcome...

10.1007/s00392-024-02557-5 article EN cc-by Clinical Research in Cardiology 2024-10-21

The antiphospholipid syndrome (APS) is an autoimmune disorder that can affect several systems, characterized by arterial, venous, or small vessel thromboembolic events caused antibodies. It often occurs as a primary event and may be secondary to systemic lupus erythematosus another disease. Occasionally, it present with acute severe condition multiple thromboses, which called catastrophic APS. authors the case of 24-year-old man, who went emergency department complaining pain in right flank,...

10.23736/s0393-3660.22.04846-x article EN Gazzetta Medica Italiana Archivio per le Scienze Mediche 2023-11-01

Introduction: Intravenous (IV) iron increases hemoglobin/hematocrit and improve outcomes in patients with heart failure reduced ejection fraction (HFrEF) deficiency. Sodium glucose co-transporter 2 inhibitors (SGLT2i) also increase HF by mechanisms linked to nutrient deprivation signaling, inflammation/oxidative stress reduction. The effect of IV among using SGLT2i has not yet been studied. Hypothesis: We hypothesize that HFrEF deficiency treated a background treatment including will have an...

10.1161/circ.148.suppl_1.11986 article EN Circulation 2023-11-07
Coming Soon ...